Kangmei Pharma | 600518 - Gross Profit On Sales

Stock Price
1.71
Daily Change
0 0%
Monthly
-2.84%
Yearly
-12.76%
Q2 Forecast
1.69

Kangmei Pharma reported CNY270.29M in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
Akebia Therapeutics USD 47.28M 1.7M Dec/2025
Alaunos Therapeutics USD -1.13M 1.11M Sep/2024
Avita Medical AUD 14.31M 639K Dec/2025
Cspc Pharmaceutical CNY 4.01B 329.18M Dec/2025
Dianthus Therapeutics USD 284K 112K Dec/2025
Genomma Lab Internacional MXN 2.66B 208.35M Mar/2026
Hypermarcas BRL 1.38B 16.08M Dec/2025
Ionis Pharmaceuticals USD 195M 40M Dec/2025
IQVIA Holdings USD 1.12B 32M Dec/2025
Jiangsu Hengrui CNY 7.27B 918.27M Dec/2025
Kangmei Pharma CNY 270.29M 20.26M Sep/2025
Moderna USD 226M 583M Dec/2025
Organon & Co USD 854M 3M Dec/2025
Revvity USD 421.66M 47.06M Dec/2025
Sh Fosun Pharma CNY 4.8B 93.72M Sep/2025
Tectonic Therapeutic USD 0 0 Mar/2025
Viatris USD 1.15B 223.6M Dec/2025
Wuxi Apptec CNY 6.34B 212.54M Dec/2025
Xeris Pharmaceuticals USD 72.15M 8.77M Dec/2025
Zz Pientze Pharmaceu CNY 296.13M 1.1B Jun/2025